Brief: CytoTools says withdraws planned convertible bonds and pursues alternatives
May 8 (Reuters) - CYTOTOOLS AG T5OG.DE :
* SAID ON FRIDAY WITHDREW PLANNED CONVERTIBLE BONDS AND
PURSUES ALTERNATIVES
* NEW FINANCIAL PLANNING FOCUSES ON THE DEVELOPMENT OF
MEDICAL DEVICES AND TAKES ACCOUNT OF THE LOWER CAPITAL
REQUIREMENTS IN THE MEDIUM TERM AS A RESULT OF THE MARKET
APPROVAL IN INDIA
Source text for Eikon: urn:newsml:reuters.com:*:nEQ6kX2rS
Further company coverage: T5OG.DE
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)